Corcept Therapeutics
CORT
#2411
Rank
S$8.27 B
Marketcap
$79.02
Share price
9.76%
Change (1 day)
133.14%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of September 2024 : S$0.50 Billion

According to Corcept Therapeutics 's latest financial reports the company has S$0.50 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.48 B-15.97%
2022-12-31S$0.57 B91.5%
2021-12-31S$0.30 B-48.17%
2020-12-31S$0.58 B56.7%
2019-12-31S$0.37 B31.71%
2018-12-31S$0.28 B137.98%
2017-12-31S$0.11 B59.13%
2016-12-31S$74.58 M30.41%
2015-12-31S$57.19 M78.52%
2014-12-31S$32.03 M-53.92%
2013-12-31S$69.52 M-38.89%
2012-12-31S$0.11 B121.64%
2011-12-31S$51.32 M62.13%
2010-12-31S$31.65 M-5.51%
2009-12-31S$33.5 M27.97%
2008-12-31S$26.18 M4.78%
2007-12-31S$24.98 M72.34%
2006-12-31S$14.49 M-70.05%
2005-12-31S$48.41 M-20.65%
2004-12-31S$61.01 M210.2%
2003-12-31S$19.66 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$26.90 B 5,236.60%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.73 B 2,028.12%๐Ÿ‡บ๐Ÿ‡ธ USA
S$18.58 B 3,586.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$4.66 B 825.08%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.41 B 1,767.03%๐Ÿ‡บ๐Ÿ‡ธ USA
S$15.05 B 2,885.26%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.25 B-50.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.32 B-34.86%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.23 B 144.64%๐Ÿ‡บ๐Ÿ‡ธ USA